Back to Search Start Over

CD4 + T Follicular Helper and IgA + B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals.

Authors :
Zaunders J
Danta M
Bailey M
Mak G
Marks K
Seddiki N
Xu Y
Templeton DJ
Cooper DA
Boyd MA
Kelleher AD
Koelsch KK
Source :
Frontiers in immunology [Front Immunol] 2016 Oct 24; Vol. 7, pp. 438. Date of Electronic Publication: 2016 Oct 24 (Print Publication: 2016).
Publication Year :
2016

Abstract

Background: Disruption of gastrointestinal tract epithelial and immune barriers contribute to microbial translocation, systemic inflammation, and progression of HIV-1 infection. Antiretroviral therapy (ART) may lead to reconstitution of CD4 <superscript>+</superscript> T cells in gut-associated lymphoid tissue (GALT), but its impact on humoral immunity within GALT is unclear. Therefore, we studied CD4 <superscript>+</superscript> subsets, including T follicular helper cells (Tfh), as well as resident B cells that have switched to IgA production, in gut biopsies, from HIV <superscript>+</superscript> subjects on suppressive ART compared to HIV-negative controls (HNC).<br />Methods: Twenty-three HIV <superscript>+</superscript> subjects on ART and 22 HNC undergoing colonoscopy were recruited to the study. Single-cell suspensions were prepared from biopsies from left colon (LC), right colon (RC), and terminal ileum (TI). T and B lymphocyte subsets, as well as EpCAM <superscript>+</superscript> epithelial cells, were accurately enumerated by flow cytometry, using counting beads.<br />Results: No significant differences in the number of recovered epithelial cells were observed between the two subject groups. However, the median TI CD4 <superscript>+</superscript> T cell count/10 <superscript>6</superscript> epithelial cells was 2.4-fold lower in HIV <superscript>+</superscript> subjects versus HNC (19,679 versus 47,504 cells; p  = 0.02). Similarly, median LC CD4 <superscript>+</superscript> T cell counts were reduced in HIV <superscript>+</superscript> subjects (8,358 versus 18,577; p  = 0.03) but were not reduced in RC. Importantly, we found no significant differences in Tfh or IgA <superscript>+</superscript> B cell counts at either site between HIV <superscript>+</superscript> subjects and HNC. Further analysis showed no difference in CD4 <superscript>+</superscript> , Tfh, or IgA <superscript>+</superscript> B cell counts between subjects who commenced ART in primary compared to chronic HIV-1 infection. Despite the decrease in total CD4 T cells, we could not identify a selective decrease of other key subsets of CD4 <superscript>+</superscript> T cells, including CCR5 <superscript>+</superscript> cells, CD127 <superscript>+</superscript> long-term memory cells, CD103 <superscript>+</superscript> tissue-resident cells, or CD161 <superscript>+</superscript> cells (surrogate marker for Th17), but there was a slight increase in the proportion of T regulatory cells.<br />Conclusion: While there were lower absolute CD4 <superscript>+</superscript> counts in the TI and LC in HIV <superscript>+</superscript> subjects on ART, they were not associated with significantly reduced Tfh cell counts or IgA <superscript>+</superscript> B cells, suggesting that this important vanguard of adaptive immune defense against luminal microbial products is normalized following ART.

Details

Language :
English
ISSN :
1664-3224
Volume :
7
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
27822211
Full Text :
https://doi.org/10.3389/fimmu.2016.00438